Hearing: Securing the U.S. Drug Supply Chain: Oversight of FDA’s Foreign Inspection Program

Subcommittee on Oversight and Investigations (Committee on Energy and Commerce)

Tuesday, December 10, 2019 (10:00 AM)

2123 RHOB
Washington, D.C.

Witnesses

Dr. Mary Denigan-Macauley, Ph.D.
Director, Healthcare, Government Accountability Office

Added 12/06/2019 at 11:43 AM
  • Witness Statement [PDF] Added 12/09/2019 at 05:49 PM
  • Questions for the Record [PDF] Added 02/13/2020 at 10:56 AM
  • Questions for the Record Responses [PDF] Added 02/13/2020 at 10:56 AM
  • Truth in Testimony [PDF] Added 12/09/2019 at 05:49 PM
  • Witness Biography [PDF] Added 12/09/2019 at 05:49 PM

Dr. Janet Woodcock, M.D.
Director, U.S. Food and Drug Administration, Center for Drug Evaluation and Research

Added 12/06/2019 at 11:56 AM
  • Witness Statement [PDF] Added 12/09/2019 at 05:49 PM
  • Witness Truth in Testimony [PDF] Added 12/09/2019 at 05:49 PM

Support Documents

  • Hearing Notice [PDF]
  • Briefing Memo [PDF] Added 12/06/2019 at 01:30 PM
  • Document for the Record - Rep. Ruiz - Widespread fraud CBS News 2019.05.10 [PDF] Added 12/11/2019 at 09:45 AM
  • Document for the Record - Rep. Ruiz - Tainted drugs NBC News 2019.05.10 [PDF] Added 12/11/2019 at 09:45 AM
  • Document for the Record - Rep. Ruiz - Data falsification STAT 2019.10.29 [PDF] Added 12/11/2019 at 09:45 AM

Member Statements

  • Opening Statement - Subcommittee Ranking Member Guthrie [PDF] Added 12/10/2019 at 03:26 PM
  • Opening Statement - Subcommittee Chair DeGette [PDF] Added 12/10/2019 at 03:26 PM
  • Opening Statement - Full Committee Ranking Member Walden [PDF] Added 12/10/2019 at 03:26 PM
  • Opening Statement - Full Committee Chairman Pallone [PDF] Added 12/10/2019 at 03:26 PM

Hearing Record

  • Hearing Transcript [PDF] Added 02/18/2020 at 01:51 PM

First Published: December 4, 2019 at 02:20 PM
Last Updated: February 18, 2020 at 05:16 PM